Resistance Training in Lung Cancer Patients on Chemotherapy

Effectiveness of a Resistance Training Program on Inflammatory Markers and Chemotherapy Completion in Lung Cancer Patients on Chemotherapy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01130714

Enrollment

Registered

2010-05-26

Start date

2010-01-31

Completion date

2012-07-31

Last updated

2015-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation, Lung Cancer

Keywords

inflammation, chemotherapy, lung cancer

Brief summary

The purpose of this study is to examine the effectiveness of a resistance training program on reducing systemic inflammation and improving chemotherapy completion in lung cancer patients being treated with curative intent chemotherapy.

Interventions

BEHAVIORALExercise

Resistance training with resistance bands.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically diagnosed with lung cancer * Stage I, II, or III * Eligible for chemotherapy with curative intent * 21 years of age or older * Approval to participate in study by treating oncologist or family physician

Exclusion criteria

* Unstable cardiac disease * Untreated bone or brain metastases

Design outcomes

Primary

Measure	Time frame
Systemic inflammation measured by c-reactive protein.	12 weeks

Secondary

Measure	Time frame
Chemotherapy completion	12 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026